Powered by:

 


The oral hCG Resarch Clinic invites you to:

The first International Workshop on hCG and obesity



Use of oral hCG for treatment of obesity: A double-blind study
(Graphics)

Figure 4 (A,B,C and D): Plicometries on four "high-responsive" skinfolds. 

Here it is shown a different series of skinfolds displaying a clear treatment-dependent behavior, most noticeable from the second week of treatment on. When last four treatment' weeks were submitted to study, MANOVA analysis resulted in nearly significant differences for factor TREATMENT and the INTERACTION.For each of these skinfolds, highly significant statistical results were found between G2 and P groups for the effect of the INTERACTION. 
In this Figures we  observe the percentages of skinfold thickness reductions, comparing data obtained at the end of the trial with the corresponding basal values (week zero). 

P values resulting from Scheffé test are marked by asterisks as follows: * p<0.05, ** p<0.0005, *** p<10-4, # p<0.01, ## p<10-6. See other details in the legend of Fig. 3 and the text.

wpe15.gif (7653 bytes)

(Click to enlarge)

wpe5.gif (8110 bytes)

(Click to enlarge)

wpe3.gif (8937 bytes)

(Click to enlarge)

wpe1.gif (8029 bytes)

(Click to enlarge)


International Workshop on hCG and obesity

International Workshop on hCG (Human Coriogonadotropin) and obesity)
September 24-26 2004 Buenos Aires, Argentina


Terms of Use

Home | About us | Advertising | Articles of Interest to Healthcare Professionals | Authorizations | Bilingual Medical Content Services | Discussion Forum | Feedback - Professionals | Feedback - Public | Help | Hospitals of Hispanic America | Indexmedico Journal | Journals | Library | Magazines | Medline | Obesity - Study | Obesity ReviewArticles of interest for the Public | Registration - Professionals | Registration - Public | Search Indexmedico |

A joint project of  Indexmedico and InterSol, Inc.

Questions? Comments?

 

Send mail to Indexmedico with questions or comments about this web site.
Copyright © 1994-2007 Indexmedico and InterSol, Inc. -  All rights reserved


15/05/2007